Rapport Therapeutics, Inc. (RAPP) analyst actions
Rating and price-target actions on RAPP in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the RAPP overview →
1 measured RAPP analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Rapport Therapeutics Announces Accelerated Initiation of RAP-219 Phase 3 Program, Expansion of Epilepsy Portfolio, and Continued Progress Across the Pipeline | Press release | -0.59% | +8.89% |
Keep exploring
More RAPP: earnings → · SEC filings → · RAPP overview →